• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    CollabRx, Inc. (CLRX)

    -NasdaqCM
    0.50 Up 0.00(0.60%) Jul 31, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    CollabRx, Inc.
    44 Montgomery Street
    Suite 800
    San Francisco, CA 94104
    United States - Map
    Phone: 415-248-5350
    Fax: 415-248-5351
    Website: http://www.collabrx.com

    Details 
    Index Membership:N/A
    Sector:Technology
    Industry:Healthcare Information Services
    Full Time Employees:13

    Business Summary 

    CollabRx, Inc. provides cloud-based expert systems to inform healthcare decision-making in the United States and internationally. The company develops and markets medical information and clinical decision support products and services. It offers Genetic Variant Annotation Service, which provides the clinical interpretation of genetic variants in human tumor biopsies; Therapy Finders, a series of cancer-specific Web-based apps that are accessed by physicians and patients; and CancerRx, a mobile app with reference tools, social media, and expert systems. The company’s cloud-based expert systems provide clinical knowledge to institutions, physicians, researchers, and patients for genomics-based medicine in cancer. The company was formerly known as Tegal Corporation and changed its name to CollabRx, Inc. in September 2012. CollabRx, Inc. was founded in 1972 and is headquartered in San Francisco, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CollabRx, Inc.

    Key Executives 
     PayExercised
    Mr. Thomas R. Mika , 64
    Chairman, Chief Exec. Officer, Pres, Acting Chief Financial Officer, Sec. and Treasurer
    304.00K0.00
    Dr. George D. Lundberg M.D., 82
    Chair of the Editorial Advisory Board, Editor-In-Chief and Chief Medical Officer
    156.00K0.00
    Mr. Clifford Baron Ph.D., 56
    Chief Operating Officer and VP
    222.00K0.00
    Mr. James Michael Karis , 67
    Consultant and Director
    N/AN/A
    Dr. Smruti J. Vidwans Ph.D.,
    Chief Science Officer and VP
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders